The genomic landscape of pediatric myelodysplastic syndromes

158Citations
Citations of this article
138Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Myelodysplastic syndromes (MDS) are uncommon in children and have a poor prognosis. In contrast to adult MDS, little is known about the genomic landscape of pediatric MDS. Here, we describe the somatic and germline changes of pediatric MDS using whole exome sequencing, targeted amplicon sequencing, and/or RNA-sequencing of 46 pediatric primary MDS patients. Our data show that, in contrast to adult MDS, Ras/MAPK pathway mutations are common in pediatric MDS (45% of primary cohort), while mutations in RNA splicing genes are rare (2% of primary cohort). Surprisingly, germline variants in SAMD9 or SAMD9L were present in 17% of primary MDS patients, and these variants were routinely lost in the tumor cells by chromosomal deletions (e.g., monosomy 7) or copy number neutral loss of heterozygosity (CN-LOH). Our data confirm that adult and pediatric MDS are separate diseases with disparate mechanisms, and that SAMD9/SAMD9L mutations represent a new class of MDS predisposition.

Cite

CITATION STYLE

APA

Schwartz, J. R., Ma, J., Lamprecht, T., Walsh, M., Wang, S., Bryant, V., … Klco, J. M. (2017). The genomic landscape of pediatric myelodysplastic syndromes. Nature Communications, 8(1). https://doi.org/10.1038/s41467-017-01590-5

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free